Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Autoimmune Disorders

  Free Subscription


06.05.2019

1 Am J Kidney Dis
2 Ann Neurol
1 Brain
3 J Autoimmun
1 J Neuroimmunol
1 J Rheumatol
1 Kidney Int
1 Lancet Child Adolesc Health
1 Neurol Clin Pract
3 Neurology
1 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Kidney Dis

  1. CHEN T, Li X, Li Y, Xia E, et al
    Prediction and Risk Stratification of Kidney Outcomes in IgA Nephropathy.
    Am J Kidney Dis. 2019 Apr 25. pii: S0272-6386(19)30618.
    PubMed     Text format     Abstract available


    Ann Neurol

  2. LIM JA, Lee ST, Chu K, Lee SK, et al
    Reply to "Grading the severity of autoimmune encephalitis: advances and pitfalls".
    Ann Neurol. 2019 May 2. doi: 10.1002/ana.25497.
    PubMed     Text format    

  3. SPAGNI G, Iorio R
    Grading the severity of autoimmune encephalitis: advances and pitfalls.
    Ann Neurol. 2019 May 2. doi: 10.1002/ana.25496.
    PubMed     Text format    


    Brain

  4. GIOVANNONI G
    Survival: the ultimate long-term outcome in multiple sclerosis.
    Brain. 2019;142:1166-1167.
    PubMed     Text format    


    J Autoimmun

  5. SEVERA M, Rizzo F, Srinivasan S, Di Dario M, et al
    A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in Multiple Sclerosis.
    J Autoimmun. 2019 Apr 29. pii: S0896-8411(19)30094.
    PubMed     Text format     Abstract available

  6. TERZIROLI BERETTA-PICCOLI B, Di Bartolomeo C, Deleonardi G, Grondona AG, et al
    Autoimmune liver serology before and after successful treatment of chronic hepatitis C by direct acting antiviral agents.
    J Autoimmun. 2019 Apr 29. pii: S0896-8411(19)30186.
    PubMed     Text format     Abstract available

  7. LIU B, Gu Y, Pei S, Peng Y, et al
    Interleukin-1 receptor associated kinase (IRAK)-M -mediated type 2 microglia polarization ameliorates the severity of experimental autoimmune encephalomyelitis (EAE).
    J Autoimmun. 2019 Apr 26. pii: S0896-8411(19)30063.
    PubMed     Text format     Abstract available


    J Neuroimmunol

  8. SETIADI AF, Abbas AR, Jeet S, Wong K, et al
    IL-17A is associated with the breakdown of the blood-brain barrier in relapsing-remitting multiple sclerosis.
    J Neuroimmunol. 2019;332:147-154.
    PubMed     Text format     Abstract available


    J Rheumatol

  9. BROUWER E, VAN DER Geest KSM, Sandovici M
    Methotrexate in Giant Cell Arteritis Deserves a Second Chance - A High-dose Methotrexate Trial Is Needed.
    J Rheumatol. 2019;46:453-454.
    PubMed     Text format    


    Kidney Int

  10. MYETTE JR, Kano T, Suzuki H, Sloan SE, et al
    A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy.
    Kidney Int. 2019 Mar 16. pii: S0085-2538(19)30174.
    PubMed     Text format     Abstract available


    Lancet Child Adolesc Health

  11. NANSEL TR
    The search for effective behavioural approaches for adolescent type 1 diabetes management.
    Lancet Child Adolesc Health. 2018;2:622-623.
    PubMed     Text format    


    Neurol Clin Pract

  12. ANGUIZOLA-TAMAYO D, Bocos-Portillo J, Pardina-Vilella L, Rodriguez-Sainz A, et al
    Psychosis of dual origin in HIV infection: Viral escape syndrome and autoimmune encephalitis.
    Neurol Clin Pract. 2019;9:178-180.
    PubMed     Text format    


    Neurology

  13. CALABRESE M, Gasperini C, Tortorella C, Schiavi G, et al
    "Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study.
    Neurology. 2019 May 1. pii: WNL.0000000000007573.
    PubMed     Text format     Abstract available

  14. BROWNLEE WJ
    Differential diagnosis of multiple sclerosis: The better explanations in clinical practice.
    Neurology. 2019 May 1. pii: WNL.0000000000007566.
    PubMed     Text format    

  15. MAILLART E, Mochel F, Acquaviva C, Maisonobe T, et al
    Severe transient myopathy in a progressive multiple sclerosis patient with high-dose biotin.
    Neurology. 2019 Apr 26. pii: WNL.0000000000007576.
    PubMed     Text format    


    PLoS One

  16. GIORDANO A, Liethmann K, Kopke S, Poettgen J, et al
    Risk knowledge of people with relapsing-remitting multiple sclerosis - Results of an international survey.
    PLoS One. 2018;13:e0208004.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  17. VOSKUHL RR, Itoh N, Tassoni A, Matsukawa MA, et al
    Gene expression in oligodendrocytes during remyelination reveals cholesterol homeostasis as a therapeutic target in multiple sclerosis.
    Proc Natl Acad Sci U S A. 2019 Apr 30. pii: 1821306116.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: